Bristol Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company focused on discovering, developing and delivering innovative medicines for patients with serious diseases. Our medicines are helping millions of patients around the world in disease areas such as oncology, cardiovascular, immunoscience, fibrosis and others.
See below for the Latest Bristol Myers Squibb News, Analysis, Profit Results, Share Price Information, and Commentary.
Bristol-Myers Squibb Japan wins Digital Innovation of the Year
Bristol-Myers Squibb Japan wins Digital Innovation of the Year
It was awarded for its PSP@SNS Platform at the Healthcare Asia Pharma Awards.
Join the community
Most Read
1. Medical device firms eye sustainability amidst regulatory changes 2. Singapore launches online tool for health insurance planning 3. Japan’s medical device market to be valued at $42.9b by 2029 4. NUH, Jaga-Me ink MoU for supportive and palliative care 5. Saudi Arabia’s pharmaceutical market to hit $16.7b by 2029Resource Center
Awards
Apr
10
Events
Event News
Co-Written / Partner
Cynosure Aesthetics and Medical APAC Services wins Healthcare Asia Medtech Awards 2024
PicoSure® Pro takes picosecond laser technology to unprecedented levels of performance.
Commentary
Why preventing diseases through adult immunisation is essential to keeping Singaporeans healthy